Oscar Health, Inc.

BST:9VY Stock Report

Market Cap: €4.3b

Oscar Health Past Earnings Performance

Past criteria checks 0/6

Oscar Health has been growing earnings at an average annual rate of 39%, while the Insurance industry saw earnings growing at 14.6% annually. Revenues have been growing at an average rate of 40.1% per year.

Key information

38.96%

Earnings growth rate

69.87%

EPS growth rate

Insurance Industry Growth5.90%
Revenue growth rate40.13%
Return on equity-13.83%
Net Margin-1.50%
Next Earnings Update06 Nov 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Oscar Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BST:9VY Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2510,726-1611,9430
31 Mar 2510,0821231,8440
31 Dec 249,178251,7560
30 Sep 248,215299710
30 Jun 247,233181,5190
31 Mar 246,535-541,3750
31 Dec 235,863-2711,3790
30 Sep 235,437-3471,1760
30 Jun 234,982-4741,0130
31 Mar 234,482-5718840
31 Dec 223,964-6061,2570
30 Sep 223,519-5796070
30 Jun 222,983-5985210
31 Mar 222,491-5594660
31 Dec 211,894-5734460
30 Sep 211,439-5713650
30 Jun 211,096-4393510
31 Mar 21682-4063040
31 Dec 20391-4142670
31 Dec 19476-2611590

Quality Earnings: 9VY is currently unprofitable.

Growing Profit Margin: 9VY is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9VY is unprofitable, but has reduced losses over the past 5 years at a rate of 39% per year.

Accelerating Growth: Unable to compare 9VY's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 9VY is unprofitable, making it difficult to compare its past year earnings growth to the Insurance industry (11.7%).


Return on Equity

High ROE: 9VY has a negative Return on Equity (-13.83%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/18 04:18
End of Day Share Price 2025/10/17 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Oscar Health, Inc. is covered by 13 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hua HaBaird
Andrew MokBarclays
Craig JonesBofA Global Research